• 1. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

Comprehensive Analysis of 3-Furancarboxylic acid, 2-cyclopropyl-5-(1-methylpropyl)- (CAS No. 2137597-53-4)

In the realm of organic chemistry, 3-Furancarboxylic acid, 2-cyclopropyl-5-(1-methylpropyl)- (CAS No. 2137597-53-4) has garnered significant attention due to its unique structural features and potential applications. This compound, characterized by its furancarboxylic acid backbone and cyclopropyl and 1-methylpropyl substituents, presents a fascinating subject for researchers and industry professionals alike. Its molecular formula and intricate architecture make it a valuable candidate for various synthetic and pharmacological studies.

The growing interest in heterocyclic compounds like 3-Furancarboxylic acid derivatives stems from their versatility in drug discovery and material science. Recent trends in green chemistry and sustainable synthesis have further propelled the exploration of such molecules, as they often exhibit lower toxicity and higher biodegradability. Researchers are particularly intrigued by the cyclopropyl group in this compound, known for its ability to enhance metabolic stability and bioavailability in pharmaceutical applications.

One of the most frequently asked questions in online searches revolves around the synthetic routes for 2-cyclopropyl-5-(1-methylpropyl)-3-furancarboxylic acid. Current literature suggests multiple pathways, including cyclization reactions of appropriate precursors or cross-coupling methodologies to introduce the 1-methylpropyl moiety. These methods align with the broader scientific community's focus on atom-economical processes and catalytic efficiency, which are critical for scalable production.

Another hot topic in discussions about CAS No. 2137597-53-4 is its potential role in flavor and fragrance industries. The furancarboxylic acid scaffold is known to contribute to aromatic profiles, and the specific substitution pattern in this compound may offer unique olfactory characteristics. This aligns with the increasing consumer demand for natural-inspired synthetic compounds in perfumery and food additives.

From a spectroscopic characterization perspective, this compound presents interesting challenges and opportunities. The presence of both aliphatic (1-methylpropyl) and cyclic (cyclopropyl) groups creates a complex NMR pattern that serves as an excellent case study for structural elucidation techniques. Advanced methods like 2D NMR and high-resolution mass spectrometry are typically employed to fully characterize such molecules.

The physicochemical properties of 3-Furancarboxylic acid, 2-cyclopropyl-5-(1-methylpropyl)- are another area of active investigation. Its logP value, solubility profile, and thermal stability are crucial parameters for various applications. These properties are particularly relevant in the context of formulation science, where understanding a compound's behavior in different media is essential for product development.

In the field of medicinal chemistry, derivatives of furancarboxylic acid have shown promise as bioactive molecules. While specific therapeutic applications of CAS No. 2137597-53-4 are still under investigation, the structural motifs present in this compound are known to interact with various biological targets. This has led to increased patent activity surrounding similar structures in recent years.

The regulatory status and safety profile of this compound are frequently searched topics. While comprehensive toxicological data may still be emerging, preliminary studies suggest that proper handling procedures should be followed, as with all chemical substances. The compound's environmental fate and ecotoxicological potential are subjects of ongoing research, particularly in light of growing environmental consciousness in chemical industries.

From an industrial perspective, the scalability of 3-Furancarboxylic acid, 2-cyclopropyl-5-(1-methylpropyl)- production is a key consideration. Process chemists are exploring continuous flow chemistry approaches to optimize its synthesis, reflecting the broader shift toward process intensification in fine chemical manufacturing. These developments are particularly relevant given the current focus on supply chain resilience in the chemical sector.

In conclusion, 3-Furancarboxylic acid, 2-cyclopropyl-5-(1-methylpropyl)- (CAS No. 2137597-53-4) represents a compelling case study in modern organic chemistry. Its structural complexity, potential applications across multiple industries, and relevance to current scientific trends make it a molecule worth watching. As research progresses, we can anticipate new insights into its properties and applications, further solidifying its position in the chemical landscape.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)